iCell Gene Therapeutics   Report issue

For profit Phase 1
Founded: New York NY United States (2014)

Organization Overview

First Clinical Trial
2018
NCT04156243
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

iCAR Bio | iCAR Bio, China | iCAR Bio Therapeutics Ltd | iCAR Bio Therapeutics Ltd. | iCell Gene Therapeutics